Information Provided By: 
Fly News Breaks for January 13, 2020
SPLK
Jan 13, 2020 | 06:29 EDT
UBS analyst Fatima Boolani raised her price target on Splunk to $176 and kept her Buy rating, also raising her implied expected 2020 earnings multiple to 9-times from 8-times. The analyst cites the combination of increased financial transparency with the disclosure of Splunk's annualized recurring revenues as well as her greater conviction in the company's share gains within the core security market.
News For SPLK From the Last 2 Days
SPLK
Apr 23, 2024 | 08:31 EDT
New option listings for April 23rd include Express Inc (EXPRQ). Option delistings effective April 23rd include PGT Innovations Inc (PGTI), NGM Biopharmaceuticals Inc (NGM), Karuna Therapeutics Inc (KRTX), KINNATE BIOPHARMA INC (KNTE), Daseke Inc (DSKE), Tritium Dcfc Ltd (DCFC), Xtrackers MSCI All China Equity ETF (CN), CymaBay Therapeutics Inc (CBAY), Alteryx Inc (AYX), XTRACKERS MSCI CHINA A INCLUSION EQUITY ETF (ASHX), Recro Pharma, Inc. (SCTL), Splunk Inc (SPLK), and Textainer Group Holdings Limited (TGH).
